NCT02944461

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Derm Research, PLLC · Academic / Other
• Sex: All
• Age: 12 Years
• Healthy volunteers: Accepted

Summary

To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk

Detailed description

This is an open label pilot study to determine the safety and efficacy of Dapsone (Aczone) 7.5% gel applied daily to the trunk for acne. Subjects will apply Dapsone for 16 weeks.

Conditions

• Acne

Interventions

Type	Name	Description
DRUG	Dapsone 7.5 % gel	Dapsone gel 7.5% applied once daily to truncal acne

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-09-01
• Completion: 2017-09-11
• First posted: 2016-10-25
• Last updated: 2019-04-03
• Results posted: 2019-03-01

Locations

3 sites across 1 country: United States